What you should know:
1. Epimède led the round, joined by several current investors.
2. Epimède Co-founder Philippe Degeer will join the company’s board of directors.
3. Endo Tool will also use the funds to support the continued development of its Endomina, endoscopy platform.
4. Endo Tool CEO Alexandre Chau said in a statement, “With technical and regulatory challenges behind us, these funds will allow Endo Tools Therapeutics to achieve further proof of efficacy of treatments performed with our devices, as well as wider adoption.”
More articles on supply chain:
Georgia widens scope of CON bill — 5 insights
Gastro Health acquiring Gastroenterology Specialists, continuing Florida expansion efforts — 4 insights
New Jersey appellate court rules on PIP procedures
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.